How is the Adaptimmune Therapeutics Plc - ADR today?

The Adaptimmune Therapeutics Plc - ADR today is trading in the down by -3.85% at 0.25.

How has Adaptimmune Therapeutics Plc - ADR performed historically?

The Adaptimmune Therapeutics Plc - ADR is currently trading down -3.85% on an intraday basis in the past week the index rose 4.17%. The index has been down -13.79% in the past quarter and fell -71.91% in the past year. You can view this in the overview section.

What is Adaptimmune Therapeutics Plc - ADR Annual Revenue?

Adaptimmune Therapeutics Plc - ADR Annual Revenue rose 195.34%, in the last year to $178.03 M. Its sector's average revenue growth for the last fiscal year was 8.76%.

What is Adaptimmune Therapeutics Plc - ADR Annual Net Profit?

Adaptimmune Therapeutics Plc - ADR Annual Net Profit rose 37.81% in the last year to $70.81 M. Its sector's average net profit growth for the last fiscal year was -14.05%.

What is Adaptimmune Therapeutics Plc - ADR Price to Earning Ratio?

Adaptimmune Therapeutics Plc - ADR Price to Earning Ratio is -0.95, which is negative.

What is Adaptimmune Therapeutics Plc - ADR Stock Price?

Adaptimmune Therapeutics Plc - ADR Stock Price fell 71.91% and underperformed its sector by 227.14% in the past year.

What is Adaptimmune Therapeutics Plc - ADR Quarterly Revenue?

Adaptimmune Therapeutics Plc - ADR Quarterly Revenue rose 28.3% YoY to $7.28 M. Its sector's average revenue growth YoY for the quarter was 3.14%.

What is Adaptimmune Therapeutics Plc - ADR Quarterly Net profit?

Adaptimmune Therapeutics Plc - ADR Quarterly Net profit rose 1.89% YoY to $47.58 M. Its sector's average net profit growth YoY for the quarter was -236.06%.

What is Adaptimmune Therapeutics Plc - ADR Debt to Equity Ratio?

Adaptimmune Therapeutics Plc - ADR Debt to Equity Ratio of 6.26 is higher than 1. This implies that company assets are financed through debt.

What is Adaptimmune Therapeutics Plc - ADR Return on Equity(ROE)?

Adaptimmune Therapeutics Plc - ADR Return on Equity(ROE) for the last financial year was -275.74%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Adaptimmune Therapeutics Plc - ADR Mutual Fund Holding?

Adaptimmune Therapeutics Plc - ADR Mutual Fund Holding decreased by 2.56% in the last quarter to 2.73.

What is Adaptimmune Therapeutics Plc - ADR Promoter Share Holding?

Adaptimmune Therapeutics Plc - ADR Promoter Share Holding stayed the same in the most recent quarter at 0.04%.

What is Adaptimmune Therapeutics Plc - ADR Interest Coverage Ratio?

Adaptimmune Therapeutics Plc - ADR Interest Coverage Ratio is -19.08, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is Adaptimmune Therapeutics Plc - ADR Institutional Holding?

Adaptimmune Therapeutics Plc - ADR Institutional Holding decreased by 3.46% in the last quarter to 43.62.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : BIOTECH
ADAPTIMMUNE THERAPEUTICS PLC - ADR

Adaptimmune Therapeutics Plc - ADR XNAS: ADAP

Adaptimmune Therapeutics Plc - ADR Live Share Price Today, Share Analysis and Chart

Name: Adaptimmune Therapeutics Plc - ADR: Is Infosys Ltd. worth buying?
Item: Adaptimmune Therapeutics Plc - ADR
Rating: 0.729319375
Author: Trendlyne DVM scores

Weak Stock

about

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer target...

0.25 -0.01 (-3.85%)

83.11% Fall from 52W High

642.3K

XNAS Volume

XNAS 20 Jun, 2025 4:00 PM (EDT)

Low Financial Strength

11.1 / 100

Expensive Valuation

15.8 / 100

Technically Bearish

20.3 / 100

Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 532%

8 analysts

Adaptimmune Therapeutics P... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Adaptimmune Therapeutics Plc - ADR Live Share Price Today, Share Analysis and Chart

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer target...

83.11% Fall from 52W High

SWOT Analysis

Adaptimmune Therapeutics P... Live Price Chart

Adaptimmune Therapeutics Plc - ADR FAQ

How is Adaptimmune Therapeutics Plc - ADR today?

Adaptimmune Therapeutics Plc - ADR today is trading in the red, and is down by -3.85% at 0.25.

How has Adaptimmune Therapeutics Plc - ADR performed historically?

Adaptimmune Therapeutics Plc - ADR is currently trading down -3.85% on an intraday basis. In the past week the stock rose 4.17%. stock has been down -13.79% in the past quarter and fell -71.91% in the past year. You can view this in the overview section.